Impact of aldosterone antagonists on the substrate for atrial fibrillation: Aldosterone promotes oxidative stress and atrial structural/electrical remodeling

This publication has 138 references indexed in Scilit:

• Oxidative Stress in the Cardiorenal Metabolic Syndrome
  Current Hypertension Reports, 2012
• Metabolic stress, reactive oxygen species, and arrhythmia
  Journal of Molecular and Cellular Cardiology, 2012
• Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase‐2 activity and expression in a model of renovascular hypertension
  British Journal of Pharmacology, 2010
• Aldosterone‐receptor antagonism as a potential therapeutic option for atrial fibrillation
  British Journal of Pharmacology, 2010
• Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing
  British Journal of Pharmacology, 2010
• Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies
  Mayo Clinic Proceedings, 2009
• Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin
  Journal of Molecular and Cellular Cardiology, 2008
• Angiotensin II induction of PDGF-C expression is mediated by AT1 receptor-dependent Egr-1 transactivation
  Nucleic Acids Research, 2008
• Interleukin-6 and atrial fibrillation in patients with coronary artery disease: Data from the Heart and Soul Study
  American Heart Journal, 2008
• Differential expression of sarcolipin protein during muscle development and cardiac pathophysiology
  Journal of Molecular and Cellular Cardiology, 2007